Vaccine Contract Manufacturing Market By Product Type (Conventional Vaccines {Live-Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines}, Novel Vaccines {Recombinant Vaccines, DNA Vaccines, mRNA Vaccines}), By Service Type (Process Development, Manufacturing Services, Analytical and Quality Control Services, Others), By Scale of Operation (Preclinical, Clinical, Commercial), By Indication (Infectious Diseases {Influenza, COVID-19, Hepatitis, Tuberculosis, Dengue, Malaria, Others}, Non-Infectious Diseases {Cancer Vaccines, Allergies, Autoimmune Diseases}), and By End-user (Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Public Health Organizations), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Vaccine Contract Manufacturing Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Advancements in mRNA and recombinant vaccine technologies

3.2.2. Significant investments in vaccine research and development fuel market growth

3.2.3. Rising cases of infectious diseases increase the need for vaccines

3.3. Key industry pitfalls & challenges

3.3.1. High capital investments are required for advanced manufacturing facilities

3.3.2. Regulatory complexities delay approvals and increase compliance costs

3.3.3. Limited production capacities create delays during high demand periods

3.4. Market Opportunities

3.4.1. Adoption of single-use bioprocessing technologies enhances manufacturing flexibility

3.4.2. Rising demand for biosimilar and biologic vaccines offers new growth prospects

3.4.3. Technological advancements in automation and AI optimize manufacturing processes

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Vaccine Contract Manufacturing Market, Product Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Product Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Conventional Vaccines

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.2. Live-Attenuated Vaccines

4.2.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.3. Inactivated Vaccines

4.2.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.4. Toxoid Vaccines

4.2.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Novel Vaccines

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.2. Recombinant Vaccines

4.3.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.3. DNA Vaccines

4.3.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.4. mRNA Vaccines

4.3.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Vaccine Contract Manufacturing Market, Service Type Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Service Type, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Process Development

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Manufacturing Services

5.3.1. Market Size and Forecast, 2025-2035(USD Billion)

5.4. Analytical and Quality Control Services

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Others

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Vaccine Contract Manufacturing Market, Scale of Operation Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Scale of Operation, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Preclinical

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Clinical

6.3.1. Market Size and Forecast, 2025-2035(USD Billion)

6.4. Commercial

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Vaccine Contract Manufacturing Market, Indication Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Indication, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Infectious Diseases

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.2.2. Influenza

7.2.2.1. Market Size and Forecast, 2025-2035(USD Billion)

7.2.3. COVID-19

7.2.3.1. Market Size and Forecast, 2025-2035(USD Billion)

7.2.4. Hepatitis

7.2.4.1. Market Size and Forecast, 2025-2035(USD Billion)

7.2.5. Tuberculosis

7.2.5.1. Market Size and Forecast, 2025-2035(USD Billion)

7.2.6. Dengue

7.2.6.1. Market Size and Forecast, 2025-2035(USD Billion)

7.2.7. Malaria

7.2.7.1. Market Size and Forecast, 2025-2035(USD Billion)

7.2.8. Others

7.2.8.1. Market Size and Forecast, 2025-2035(USD Billion)

7.3. Non-Infectious Diseases

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3.2. Cancer Vaccines

7.3.2.1. Market Size and Forecast, 2025-2035(USD Billion)

7.3.3. Allergies

7.3.3.1. Market Size and Forecast, 2025-2035(USD Billion)

7.3.4. Autoimmune Diseases

7.3.4.1. Market Size and Forecast, 2025-2035(USD Billion)

8. Vaccine Contract Manufacturing Market, End-user Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By End-user, 2025 & 2035

8.1.2. Key Market Trends, Growth Factors, & Opportunities

8.2. Pharmaceutical Companies

8.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.3. Biotechnology Companies

8.3.1. Market Size and Forecast, 2025-2035(USD Billion)

8.4. Research Institutes

8.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.5. Public Health Organizations

8.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

9. Vaccine Contract Manufacturing Market, Region Segment Analysis

9.1. Overview

9.1.1. Global Market Revenue Share, By Region, 2025 & 2035

9.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

9.2. North America

9.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

9.2.2. North America Market Revenue, By Product Type, 2025-2035

9.2.3. North America Market Revenue, By Service Type, 2025-2035

9.2.4. North America Market Revenue, By Scale of Operation, 2025-2035

9.2.5. North America Market Revenue, By Indication, 2025-2035

9.2.6. North America Market Revenue, By End-user, 2025-2035

9.2.7. The U.S.

9.2.7.1. U.S. Market Revenue, By Product Type, 2025-2035

9.2.7.2. U.S. Market Revenue, By Service Type, 2025-2035

9.2.7.3. U.S. Market Revenue, By Scale of Operation, 2025-2035

9.2.7.4. U.S. Market Revenue, By Indication, 2025-2035

9.2.7.5. U.S. Market Revenue, By End-user, 2025-2035

9.2.8. Canada

9.2.8.1. Canada Market Revenue, By Product Type, 2025-2035

9.2.8.2. Canada Market Revenue, By Service Type, 2025-2035

9.2.8.3. Canada Market Revenue, By Scale of Operation, 2025-2035

9.2.8.4. Canada Market Revenue, By Indication, 2025-2035

9.2.8.5. Canada Market Revenue, By End-user, 2025-2035

9.3. Europe

9.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)

9.3.2. Europe Market Revenue, By Product Type, 2025-2035

9.3.3. Europe Market Revenue, By Service Type, 2025-2035

9.3.4. Europe Market Revenue, By Scale of Operation, 2025-2035

9.3.5. Europe Market Revenue, By Indication, 2025-2035

9.3.6. Europe Market Revenue, By End-user, 2025-2035

9.3.7. Germany

9.3.7.1. Germany Market Revenue, By Product Type, 2025-2035

9.3.7.2. Germany Market Revenue, By Service Type, 2025-2035

9.3.7.3. Germany Market Revenue, By Scale of Operation, 2025-2035

9.3.7.4. Germany Market Revenue, By Indication, 2025-2035

9.3.7.5. Germany Market Revenue, By End-user, 2025-2035

9.3.8. France

9.3.8.1. France Market Revenue, By Product Type, 2025-2035

9.3.8.2. France Market Revenue, By Service Type, 2025-2035

9.3.8.3. France Market Revenue, By Scale of Operation, 2025-2035

9.3.8.4. France Market Revenue, By Indication, 2025-2035

9.3.8.5. France Market Revenue, By End-user, 2025-2035

9.3.9. U.K.

9.3.9.1. U.K. Market Revenue, By Product Type, 2025-2035

9.3.9.2. U.K. Market Revenue, By Service Type, 2025-2035

9.3.9.3. U.K. Market Revenue, By Scale of Operation, 2025-2035

9.3.9.4. U.K. Market Revenue, By Indication, 2025-2035

9.3.9.5. U.K. Market Revenue, By End-user, 2025-2035

9.3.10. Italy

9.3.10.1. Italy Market Revenue, By Product Type, 2025-2035

9.3.10.2. Italy Market Revenue, By Service Type, 2025-2035

9.3.10.3. Italy Market Revenue, By Scale of Operation, 2025-2035

9.3.10.4. Italy Market Revenue, By Indication, 2025-2035

9.3.10.5. Italy Market Revenue, By End-user, 2025-2035

9.3.11. Spain

9.3.11.1. Spain Market Revenue, By Product Type, 2025-2035

9.3.11.2. Spain Market Revenue, By Service Type, 2025-2035

9.3.11.3. Spain Market Revenue, By Scale of Operation, 2025-2035

9.3.11.4. Spain Market Revenue, By Indication, 2025-2035

9.3.11.5. Spain Market Revenue, By End-user, 2025-2035

9.3.12. Rest of Europe

9.3.12.1. Rest of Europe Market Revenue, By Product Type, 2025-2035

9.3.12.2. Rest of Europe Market Revenue, By Service Type, 2025-2035

9.3.12.3. Rest of Europe Market Revenue, By Scale of Operation, 2025-2035

9.3.12.4. Rest of Europe Market Revenue, By Indication, 2025-2035

9.3.12.5. Rest of Europe Market Revenue, By End-user, 2025-2035

9.4. Asia Pacific

9.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)

9.4.2. Asia Pacific Market Revenue, By Product Type, 2025-2035

9.4.3. Asia Pacific Market Revenue, By Service Type, 2025-2035

9.4.4. Asia Pacific Market Revenue, By Scale of Operation, 2025-2035

9.4.5. Asia Pacific Market Revenue, By Indication, 2025-2035

9.4.6. Asia Pacific Market Revenue, By End-user, 2025-2035

9.4.7. China

9.4.7.1. China Market Revenue, By Product Type, 2025-2035

9.4.7.2. China Market Revenue, By Service Type, 2025-2035

9.4.7.3. China Market Revenue, By Scale of Operation, 2025-2035

9.4.7.4. China Market Revenue, By Indication, 2025-2035

9.4.7.5. China Market Revenue, By End-user, 2025-2035

9.4.8. Japan

9.4.8.1. Japan Market Revenue, By Product Type, 2025-2035

9.4.8.2. Japan Market Revenue, By Service Type, 2025-2035

9.4.8.3. Japan Market Revenue, By Scale of Operation, 2025-2035

9.4.8.4. Japan Market Revenue, By Indication, 2025-2035

9.4.8.5. Japan Market Revenue, By End-user, 2025-2035

9.4.9. India

9.4.9.1. India Market Revenue, By Product Type, 2025-2035

9.4.9.2. India Market Revenue, By Service Type, 2025-2035

9.4.9.3. India Market Revenue, By Scale of Operation, 2025-2035

9.4.9.4. India Market Revenue, By Indication, 2025-2035

9.4.9.5. India Market Revenue, By End-user, 2025-2035

9.4.10. Australia

9.4.10.1. Australia Market Revenue, By Product Type, 2025-2035

9.4.10.2. Australia Market Revenue, By Service Type, 2025-2035

9.4.10.3. Australia Market Revenue, By Scale of Operation, 2025-2035

9.4.10.4. Australia Market Revenue, By Indication, 2025-2035

9.4.10.5. Australia Market Revenue, By End-user, 2025-2035

9.4.11. South Korea

9.4.11.1. South Korea Market Revenue, By Product Type, 2025-2035

9.4.11.2. South Korea Market Revenue, By Service Type, 2025-2035

9.4.11.3. South Korea Market Revenue, By Scale of Operation, 2025-2035

9.4.11.4. South Korea Market Revenue, By Indication, 2025-2035

9.4.11.5. South Korea Market Revenue, By End-user, 2025-2035

9.4.12. Singapore

9.4.12.1. Singapore Market Revenue, By Product Type, 2025-2035

9.4.12.2. Singapore Market Revenue, By Service Type, 2025-2035

9.4.12.3. Singapore Market Revenue, By Scale of Operation, 2025-2035

9.4.12.4. Singapore Market Revenue, By Indication, 2025-2035

9.4.12.5. Singapore Market Revenue, By End-user, 2025-2035

9.4.13. Rest of Asia Pacific

9.4.13.1. Rest of Asia Pacific Market Revenue, By Product Type, 2025-2035

9.4.13.2. Rest of Asia Pacific Market Revenue, By Service Type, 2025-2035

9.4.13.3. Rest of Asia Pacific Market Revenue, By Scale of Operation, 2025-2035

9.4.13.4. Rest of Asia Pacific Market Revenue, By Indication, 2025-2035

9.4.13.5. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

9.5. Latin America

9.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)

9.5.2. Latin America Market Revenue, By Product Type, 2025-2035

9.5.3. Latin America Market Revenue, By Service Type, 2025-2035

9.5.4. Latin America Market Revenue, By Scale of Operation, 2025-2035

9.5.5. Latin America Market Revenue, By Indication, 2025-2035

9.5.6. Latin America Market Revenue, By End-user, 2025-2035

9.5.7. Brazil

9.5.7.1. Brazil Market Revenue, By Product Type, 2025-2035

9.5.7.2. Brazil Market Revenue, By Service Type, 2025-2035

9.5.7.3. Brazil Market Revenue, By Scale of Operation, 2025-2035

9.5.7.4. Brazil Market Revenue, By Indication, 2025-2035

9.5.7.5. Brazil Market Revenue, By End-user, 2025-2035

9.5.8. Argentina

9.5.8.1. Argentina Market Revenue, By Product Type, 2025-2035

9.5.8.2. Argentina Market Revenue, By Service Type, 2025-2035

9.5.8.3. Argentina Market Revenue, By Scale of Operation, 2025-2035

9.5.8.4. Argentina Market Revenue, By Indication, 2025-2035

9.5.8.5. Argentina Market Revenue, By End-user, 2025-2035

9.5.9. Mexico

9.5.9.1. Mexico Market Revenue, By Product Type, 2025-2035

9.5.9.2. Mexico Market Revenue, By Service Type, 2025-2035

9.5.9.3. Mexico Market Revenue, By Scale of Operation, 2025-2035

9.5.9.4. Mexico Market Revenue, By Indication, 2025-2035

9.5.9.5. Mexico Market Revenue, By End-user, 2025-2035

9.5.10. Rest of Latin America

9.5.10.1. Rest of Latin America Market Revenue, By Product Type, 2025-2035

9.5.10.2. Rest of Latin America Revenue, By Service Type, 2025-2035

9.5.10.3. Rest of Latin America Market Revenue, By Scale of Operation, 2025-2035

9.5.10.4. Rest of Latin America Market Revenue, By Indication, 2025-2035

9.5.10.5. Rest of Latin America Market Revenue, By End-user, 2025-2035

9.6. MEA

9.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)

9.6.2. MEA Market Revenue, By Product Type, 2025-2035

9.6.3. MEA Market Revenue, By Service Type, 2025-2035

9.6.4. MEA Market Revenue, By Scale of Operation, 2025-2035

9.6.5. MEA Market Revenue, By Indication, 2025-2035

9.6.6. MEA Market Revenue, By End-user, 2025-2035

9.6.7. GCC Countries

9.6.7.1. GCC Countries Market Revenue, By Product Type, 2025-2035

9.6.7.2. GCC Countries Market Revenue, By Service Type, 2025-2035

9.6.7.3. GCC Countries Market Revenue, By Scale of Operation, 2025-2035

9.6.7.4. GCC Countries Market Revenue, By Indication, 2025-2035

9.6.7.5. GCC Countries Market Revenue, By End-user, 2025-2035

9.6.8. South Africa

9.6.8.1. South Africa Market Revenue, By Product Type, 2025-2035

9.6.8.2. South Africa Market Revenue, By Service Type, 2025-2035

9.6.8.3. South Africa Market Revenue, By Scale of Operation, 2025-2035

9.6.8.4. South Africa Market Revenue, By Indication, 2025-2035

9.6.8.5. South Africa Market Revenue, By End-user, 2025-2035

9.6.9. Rest of Middle-East & Africa

9.6.9.1. Rest of Middle East & Africa Market Revenue, By Product Type, 2025-2035

9.6.9.2. Rest of Middle East & Africa Market Revenue, By Service Type, 2025-2035

9.6.9.3. Rest of Middle East & Africa Market Revenue, By Scale of Operation, 2025-2035

9.6.9.4. Rest of Middle East & Africa Market Revenue, By Indication, 2025-2035

9.6.9.5. Rest of Middle East & Africa Market Revenue, By End-user, 2025-2035

10. Company Profile

10.1. Lonza Group AG

10.1.1. Business Overview

10.1.2. Financial Performance

10.1.3. Product/Service Offerings

10.1.4. Strategies & recent developments

10.1.5. SWOT Analysis

10.2. Catalent Inc.

10.2.1. Business Overview

10.2.2. Financial Performance

10.2.3. Product/Service Offerings

10.2.4. Strategies & recent developments

10.2.5. SWOT Analysis

10.3. WuXi Biologics

10.3.1. Business Overview

10.3.2. Financial Performance

10.3.3. Product/Service Offerings

10.3.4. Strategies & recent developments

10.3.5. SWOT Analysis

10.4. Samsung Biologics

10.4.1. Business Overview

10.4.2. Financial Performance

10.4.3. Product/Service Offerings

10.4.4. Strategies & recent developments

10.4.5. SWOT Analysis

10.5. Emergent BioSolutions

10.5.1. Business Overview

10.5.2. Financial Performance

10.5.3. Product/Service Offerings

10.5.4. Strategies & recent developments

10.5.5. SWOT Analysis

10.6. Ajinomoto Bio-Pharma Services

10.6.1. Business Overview

10.6.2. Financial Performance

10.6.3. Product/Service Offerings

10.6.4. Strategies & recent developments

10.6.5. SWOT Analysis

10.7. Curia Global

10.7.1. Business Overview

10.7.2. Financial Performance

10.7.3. Product/Service Offerings

10.7.4. Strategies & recent developments

10.7.5. SWOT Analysis

10.8. Charles River Laboratories International Inc.

10.8.1. Business Overview

10.8.2. Financial Performance

10.8.3. Product/Service Offerings

10.8.4. Strategies & recent developments

10.8.5. SWOT Analysis

10.9. IDT Biologika GmbH

10.9.1. Business Overview

10.9.2. Financial Performance

10.9.3. Product/Service Offerings

10.9.4. Strategies & recent developments

10.9.5. SWOT Analysis

10.10. Fujifilm Diosynth Biotechnologies

10.10.1. Business Overview

10.10.2. Financial Performance

10.10.3. Product/Service Offerings

10.10.4. Strategies & recent developments

10.10.5. SWOT Analysis

10.11. Recipharm AB

10.11.1. Business Overview

10.11.2. Financial Performance

10.11.3. Product/Service Offerings

10.11.4. Strategies & recent developments

10.11.5. SWOT Analysis

10.12. Gedeon Richter

10.12.1. Business Overview

10.12.2. Financial Performance

10.12.3. Product/Service Offerings

10.12.4. Strategies & recent developments

10.12.5. SWOT Analysis

10.13. Serum Institute of India

10.13.1. Business Overview

10.13.2. Financial Performance

10.13.3. Product/Service Offerings

10.13.4. Strategies & recent developments

10.13.5. SWOT Analysis

10.14. Bharat Biotech

10.14.1. Business Overview

10.14.2. Financial Performance

10.14.3. Product/Service Offerings

10.14.4. Strategies & recent developments

10.14.5. SWOT Analysis

10.15. Hester Biosciences

10.15.1. Business Overview

10.15.2. Financial Performance

10.15.3. Product/Service Offerings

10.15.4. Strategies & recent developments

10.15.5. SWOT Analysis